Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study
about
Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathiesCystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyAssociation of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul StudyEarly detection of diabetic kidney disease: Present limitations and future perspectivesChronic kidney disease screening methods and its implication for Malaysia: an in depth reviewInflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)New susceptibility loci associated with kidney disease in type 1 diabetes.Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data.Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).Diabetic Nephropathy: New Risk Factors and Improvements in DiagnosisPredictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians.Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study.Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-upRelationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.Association of cystatin C with adverse outcomes.Development and validation of GFR-estimating equations using diabetes, transplant and weightThe association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family StudyAssociations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyEffect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.Proteomic discovery of diabetic nephropathy biomarkers.Cystatin C identifies chronic kidney disease patients at higher risk for complications.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study.Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.Risks of rapid decline renal function in patients with type 2 diabetesLongitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes.Kidney function and clinical recommendations of drug dose adjustment in geriatric patients.Effect of enhanced external counterpulsation treatment on renal function in cardiac patients.Improving prognosis estimation in patients with heart failure and the cardiorenal syndromeRace differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations.Racial and ethnic differences in kidney function decline among persons without chronic kidney diseaseEvolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetesRacial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.
P2860
Q21558546-05C89DBD-9526-4397-BA81-3079BB594973Q24635177-F4B55BF1-6F28-4811-985E-DE4EC5EC9296Q24646339-85186919-AD16-4251-919E-40D5C2D3803DQ26741494-EB3FEB8C-B3DF-4893-A789-6ED3387D2FE8Q26822369-515097F2-3889-402D-A728-9F94A6A12FBCQ28387350-33A90A74-7BB9-4C3B-880D-7175290DB28BQ29417066-0E8EB64D-8DA1-4CB9-93A2-F3A806E97DC5Q30423005-C7E7913E-BD59-4DEE-904D-EAA83BE09D09Q31067194-88361123-9724-4C9C-9FD5-B6DA91100E0AQ31071745-6F5858F6-A22C-4678-8307-ADF32DC242B4Q31112191-FDC5585E-E809-4260-A623-1B8854D435A5Q33357921-661658F9-BC12-4BB4-BDD0-FF6653CECA4CQ33562005-80BC5ECA-3CC9-4ADE-9092-A84CFCED85D0Q33583018-6236F4BF-FC2D-40F3-8E45-F55568752B4AQ33591588-453B0B11-B998-4621-933F-18795C0F9D32Q33608612-16A012DB-9A15-411F-856D-EF401962835AQ33617174-FE5355A3-D09E-4860-8ED5-7CE8EF4DD91AQ33646576-0DEED426-7BD4-40BA-888C-9C0F9767690FQ33819382-9E8D6E7A-B1FE-4284-A488-C3756A9EDCB4Q33873169-6E9BD22C-BFB1-4AC5-B49C-85750B1E8B7AQ33905277-B021F191-765D-4D1E-BE00-CB41721A9350Q33932292-037E08A1-3488-477C-9DC5-9ABA4DD1CF83Q34021345-5ADC4D8C-00E5-41DE-B43A-D3872ABA665DQ34092120-BA76701F-B93E-4AB3-B0FE-11B6968A9413Q34150807-E5344C7C-6172-40C5-8784-221EAB5F48A8Q34292912-7988834E-B4DA-4F12-92EE-CC85490AACFDQ34330236-C9766363-0BEE-4D43-A63B-18F391F7B796Q34457290-07B7858F-1CEC-482C-AFF4-57074AD19D64Q34519960-3F44FA61-7AEE-4F1B-BF81-C738128FD5BBQ34538110-A096B055-4EE4-4461-B40E-244725C47FE8Q34699197-E6B29709-5136-4E7D-9980-867FF2DA2ACBQ34751900-96CDBF4C-7ACE-479B-BB7D-D2D46D5D7339Q34983087-273F5FCC-D4EE-4928-B8AE-773C67E2231DQ34983153-971EE35D-0533-4B27-8A69-30A04C9EF1A3Q35020305-CE0BC416-A408-40EB-9096-D6FA3011EBDDQ35025494-2D4861DA-EC4F-48CD-8AB8-BE2320EEC543Q35108889-31FF7A76-C92A-403C-8733-3D8E512D98B7Q35123425-1882D83D-990C-4727-8ED6-4848C80F452AQ35133148-8DAF45A3-07C6-4E49-BF6D-A698FF935A11Q35189566-ABFB10D6-9155-42BA-8F9D-58EACEF860BC
P2860
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Detection of renal function de ...... ts of a 4-year follow-up study
@ast
Detection of renal function de ...... ts of a 4-year follow-up study
@en
Detection of renal function de ...... ts of a 4-year follow-up study
@nl
type
label
Detection of renal function de ...... ts of a 4-year follow-up study
@ast
Detection of renal function de ...... ts of a 4-year follow-up study
@en
Detection of renal function de ...... ts of a 4-year follow-up study
@nl
prefLabel
Detection of renal function de ...... ts of a 4-year follow-up study
@ast
Detection of renal function de ...... ts of a 4-year follow-up study
@en
Detection of renal function de ...... ts of a 4-year follow-up study
@nl
P2093
P2860
P3181
P356
P1476
Detection of renal function de ...... ts of a 4-year follow-up study
@en
P2093
Andrzej S Krolewski
Betsy E P Ostrander
Bruce A Perkins
Bryan D Myers
James H Warram
Kristina L Blouch
Robert G Nelson
P2860
P304
P3181
P356
10.1681/ASN.2004100854
P407
P577
2005-05-01T00:00:00Z